Tue, April 2, 2024

Mitchell Kapoor Maintained (carm) at Strong Buy with Decreased Target to $9 on, Apr 2nd, 2024

Mitchell Kapoor of HC Wainwright & Co., Maintained "Carisma Therapeutics, Inc." (CARM) at Strong Buy with Decreased Target from $11 to $9 on, Apr 2nd, 2024.

Mitchell, nor any peers, have made any analyst calls on CARM in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30